Amarin Shares Spiking (AMRN)

Amarin AMRN shares began spiking around a half hour ago and are currently up 4.41% to $17.30. The company is providing additional details with regard to its successful MARINE Phase III Trial at the National Lipid Association 2011 Annual Scientific Sessions today. Amarin Corporation plc (Amarin) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. The Company's development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease.